These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6200722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of canine coronary collateral flow by nafazatrom.
    Fiedler VB, Mardin M.
    Eur J Pharmacol; 1986 Nov 04; 130(3):157-67. PubMed ID: 3792445
    [Abstract] [Full Text] [Related]

  • 8. The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.
    Shea MJ, Driscoll EM, Romson JL, Pitt B, Lucchesi BR.
    Am Heart J; 1984 Apr 04; 107(4):629-37. PubMed ID: 6702555
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ, Parratt JR.
    J Mol Cell Cardiol; 1984 Jan 04; 16(1):43-52. PubMed ID: 6366241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of ortho-iodo sodium benzoate on acute myocardial ischemia, hemodynamic function, and infarct size after coronary artery occlusion in dogs.
    Rude RE, Tumas J, Gunst M, Kloner RA, DeBoer LW, Maroko PR.
    Am J Cardiol; 1983 May 01; 51(8):1422-7. PubMed ID: 6846170
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat.
    Fiedler VB.
    Eur J Pharmacol; 1983 Mar 25; 88(2-3):263-7. PubMed ID: 6852112
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of hyaluronidase in decreasing myocardial ischemia post coronary occlusion in the isolated perfused rabbit heart.
    Wetstein L, Simson MB, Haselgrove J, Barlow CH, Harken AH.
    Am Heart J; 1982 Sep 25; 104(3):529-36. PubMed ID: 7113892
    [Abstract] [Full Text] [Related]

  • 17. Nafazatrom (BAY g 6575), a potent stimulator of prostacyclin release from cardiac and renal vessel wall.
    Klitzke AK.
    Arch Int Pharmacodyn Ther; 1984 Oct 25; 271(2):220-8. PubMed ID: 6391401
    [Abstract] [Full Text] [Related]

  • 18. Left atrium-to-femoral artery bypass: effectiveness in reduction of acute experimental myocardial infarction.
    Catinella FP, Cunningham JN, Glassman E, Laschinger JC, Baumann FG, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Dec 25; 86(6):887-96. PubMed ID: 6645591
    [Abstract] [Full Text] [Related]

  • 19. Protective actions of nafazatrom in traumatic shock.
    Lefer AM, Messenger M.
    Arzneimittelforschung; 1982 Dec 25; 32(9):1089-91. PubMed ID: 6890831
    [Abstract] [Full Text] [Related]

  • 20. Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats.
    Feuerstein G, Bayorh MA, Stull R, Goldstein DS, Zerbe RL, Ramwell PW, Faden AI.
    Circ Shock; 1985 Dec 25; 17(3):223-32. PubMed ID: 3841032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.